AI-generated summary
The authors reviewed 75 controlled clinical studies of photobiomodulation for oral mucositis published over roughly 20 years, focusing on devices, protocols and outcomes. They report that comparing outcomes across protocols was not feasible because treatment parameters were often missing and measurements were not homogeneous. The authors conclude that a lack of standardization is the main barrier, and that additional randomized trials with well-described methods are needed.
- Studies included
- 75
- Who or what was studied
- Patients with oral mucositis, predominantly head and neck chemoradiation patients in included controlled studies
- Limits stated in the abstract
- Comparison of protocols was unfeasible due to missing treatment parameters and nonhomogeneous outcome measurements.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Placebo-controlled, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.